These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15880352)

  • 1. Prevalence estimates of recurrent balanced cytogenetic aberrations and gene fusions in unselected patients with neoplastic disorders.
    Mitelman F; Mertens F; Johansson B
    Genes Chromosomes Cancer; 2005 Aug; 43(4):350-66. PubMed ID: 15880352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer.
    Mitelman F; Johansson B; Mertens F
    Nat Genet; 2004 Apr; 36(4):331-4. PubMed ID: 15054488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary vs. secondary neoplasia-associated chromosomal abnormalities--balanced rearrangements vs. genomic imbalances?
    Johansson B; Mertens F; Mitelman F
    Genes Chromosomes Cancer; 1996 Jul; 16(3):155-63. PubMed ID: 8814447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired chromosomal rearrangements targeting selected transcription factors: contribution of molecular cytogenetic and expression analyses to the identification of clinically and biologically relevant subgroups in hematological malignancies.
    Poppe B; De Paepe A; Speleman F
    Verh K Acad Geneeskd Belg; 2007; 69(1):47-64. PubMed ID: 17427874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of translocations and gene fusions on cancer causation.
    Mitelman F; Johansson B; Mertens F
    Nat Rev Cancer; 2007 Apr; 7(4):233-45. PubMed ID: 17361217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there an association with constitutional structural chromosomal abnormalities and hematologic neoplastic process? A short review.
    Panani AD
    Ann Hematol; 2009 Apr; 88(4):293-9. PubMed ID: 19129995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumor-type specific translocations methods and indications for routine molecular pathology].
    Gattenlöhner S; Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 2007; 91():154-9. PubMed ID: 18314609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal aberrations in solid tumors.
    Chinnaiyan AM; Palanisamy N
    Prog Mol Biol Transl Sci; 2010; 95():55-94. PubMed ID: 21075329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular cytogenetics in diagnostics of malignant diseases].
    Michalová K; Zemanová Z
    Cas Lek Cesk; 2006; 145(7):532-7. PubMed ID: 16921780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ring chromosomes in human neoplasias.
    Gebhart E
    Cytogenet Genome Res; 2008; 121(3-4):149-73. PubMed ID: 18758155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biological importance of cytogenetic abnormalities in childhood and adult acute lymphoblastic leukemia.
    Johansson B; Mertens F; Mitelman F
    Ann Med; 2004; 36(7):492-503. PubMed ID: 15513300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal chromosome abnormalities in neoplastic cells: evidence of genetic instability?
    Heim S
    Cancer Surv; 1996; 28():247-60. PubMed ID: 8977039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic and molecular aspects of Philadelphia negative chronic myeloproliferative disorders: clinical implications.
    Panani AD
    Cancer Lett; 2007 Sep; 255(1):12-25. PubMed ID: 17383090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple numerical chromosome aberrations in cancer: what are their causes and what are their consequences?
    Teixeira MR; Heim S
    Semin Cancer Biol; 2005 Feb; 15(1):3-12. PubMed ID: 15613283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rearrangement of chromosomal region 8q11-13 in lipomatous tumours: correlation with lipoblastoma morphology.
    Brandal P; Bjerkehagen B; Heim S
    J Pathol; 2006 Feb; 208(3):388-94. PubMed ID: 16308870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of submicroscopic deletions vary according to disease entities and chromosomal translocations in hematologic malignancies: investigation by fluorescence in situ hybridization.
    Moon HW; Chang YH; Kim TY; Oh BR; Min HC; Kim BK; Ahn HS; Cho HI; Lee DS
    Cancer Genet Cytogenet; 2007 Jun; 175(2):166-8. PubMed ID: 17556074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal abnormalities and tumor development: from genes to therapeutic mechanisms.
    Cobaleda C; Pérez-Losada J; Sánchez-García I
    Bioessays; 1998 Nov; 20(11):922-30. PubMed ID: 9872058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FISH panels for hematologic malignancies.
    Sreekantaiah C
    Cytogenet Genome Res; 2007; 118(2-4):284-96. PubMed ID: 18000382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stochastic cancer progression driven by non-clonal chromosome aberrations.
    Heng HH; Stevens JB; Liu G; Bremer SW; Ye KJ; Reddy PV; Wu GS; Wang YA; Tainsky MA; Ye CJ
    J Cell Physiol; 2006 Aug; 208(2):461-72. PubMed ID: 16688757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal abnormalities: detection and implications for cancer development.
    Dos Santos NR; Van Kessel AG
    Anticancer Res; 1999; 19(6A):4697-714. PubMed ID: 10697586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.